Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study-Reference-Cited by-同舟云学术

Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study

Published:2011-09 Issue:9 Volume:35 Page:1184-1187
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Sánchez-Guijo Fermin M.,Durán Soledad,Galende Josefina,Boqué Concepción,Nieto José B.,Balanzat Josep,Gracia Antonio,García Isabel,Avellaneda-Molina Carmen,Moreno María-Victoria,Luño-Fernandez Elisa,Hermosilla Mar,Sanchez-Varela José Manuel,Dios Ana,López-Garrido Pilar,Giraldo Pilar,Bargay Joan,Domingo José María,Soler Alfonso,Salinas Ramón,del Cañizo Maria-Consuelo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference13 articles.

1. Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?;Valent;Eur J Clin Invest,2010

2. Epidemiology of chronic myeloid leukaemia (CML);Rohrbacher;Best Pract Res Clin Haematol,2009

3. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet;Baccarani;J Clin Oncol,2009

4. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

5. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group;Hasford;J Natl Cancer Inst,1998

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse;Nature Cancer;2023-03-13

2. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience;Clinical Lymphoma Myeloma and Leukemia;2021-08

3. Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis;Journal of Internal Medicine;2020-07-13

4. Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population‐based study;European Journal of Haematology;2019-08-28

5. First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter;Leukemia Research;2019-06